A Phase I/II National, Multi-Center, Open-Label Study of Bortezomib Plus Melphalan and Prednisone (V-MP) in Elderly Untreated Multiple Myeloma Patients.

MV Mateos, Jesús F. San Miguel, Joaquín Díaz Mediavilla et al.|Blood|2004

Cited by 39